Novo’s Home Country Pays 31 Obesity Drug Users for Eye Condition
Denmark has granted 15 million kroner ($2.2 million) in compensation to 31 people who developed a rare but serious eye condition after using Novo Nordisk A/S’s weight-loss medicines as the safety issue grows in the drugmaker’s home country.
Editorial & Syndication Notice: This story has been syndicated or published by 360 NEWS in accordance with verified fair-use, official press dissemination, and original attribution protocols. All trademarks, photos, and referenced quotes remain the property of their respective owners. For editorial corrections, press inquiries, or rights notices, contact [email protected].

